The role of Interleukin-21 in the pathogenesis of autoimmune diabetes
The role of Interleukin-21 in the pathogenesis of autoimmune diabetes
批准号:
nhmrc : 358307
负责人:
A/Pr Cecile King
金额:
$34.61万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
T cells are a component of our blood (white blood cells) and a major component of the body's defense system against infection, known as immunity. Without T cells, we would fail to resist infection by foreign agents, such as viruses, bacteria and fungi. Autoimmune (type 1) diabetes is a disease in which T cells attack our own pancreatic islet self tissues as if they were foreign. T cells that react against the islets of the pancreas cause destruction of the insulin producing beta cells so that the pancreas can no longer make insulin. Diabetes is a life-threatening disease because insulin is a hormone that enables people to get energy from food. Type 1 diabetes is usually diagnosed in childhood and insulin must be administered daily by injection or through a pump in order to survive. Unfortunately, taking insulin doesn t cure diabetes and people continue to suffer from an extensive list of complications affecting most vital organs. Interleukin-21 (IL-21) is a soluble protein that is produced by cells enabling them to communicate with other cells. IL-21 helps cells to produce factors that cause inflammation and assist in clearance of viruses and bacteria from the body. However, our studies show that IL-21 is a major factor in the development of the T cells that destroy beta cells and cause diabetes. Our studies show that IL-21 is over-expressed in an important murine model of spontaneous type-1 diabetes. We have isolated the T cells that cause diabetes and show that they are distinguished from other T cells by very high levels of the receptor for IL-21. This project focuses on the IL-21-responsive T cells that cause diabetes and aims to determine the mechanisms by which the cytokine IL-21 causes destructive immune responses and ways to modulate its production. This project applies basic science to the important public health issue of type 1 diabetes for the development of therapeutic intervention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Action of Interleukin-2 Superkines
-
批准号:nhmrc : GNT1148051
-
项目类别:Project Grants
-
资助金额:$72.56万
-
财政年份:2018
-
负责人:A/Pr Cecile King
-
依托单位:
Mechanisms of Action of Interleukin-2 Superkines
-
批准号:nhmrc : 1148051
-
项目类别:Project Grants
-
资助金额:$49.06万
-
财政年份:2018
-
负责人:A/Pr Cecile King
-
依托单位:
Interleukin signalling in CD4+ T cell differentiation
-
批准号:nhmrc : 1087408
-
项目类别:Project Grants
-
资助金额:$44.27万
-
财政年份:2015
-
负责人:A/Pr Cecile King
-
依托单位:
Interleukin signalling in CD4+ T cell differentiation
-
批准号:nhmrc : GNT1087408
-
项目类别:Project Grants
-
资助金额:$64.31万
-
财政年份:2015
-
负责人:A/Pr Cecile King
-
依托单位:
Identifying the ontogeny and fate of T follicular helper cells by two-photon photoconversion
-
批准号:nhmrc : 1062332
-
项目类别:Project Grants
-
资助金额:$41.55万
-
财政年份:2014
-
负责人:A/Pr Cecile King
-
依托单位:
CCR9 expressing T helper cells in immunity and autoimmunity
-
批准号:nhmrc : 1066243
-
项目类别:Project Grants
-
资助金额:$48.65万
-
财政年份:2014
-
负责人:A/Pr Cecile King
-
依托单位:
CD8 T cell regulation of humoral immune responses
-
批准号:nhmrc : 1029942
-
项目类别:Project Grants
-
资助金额:$40.12万
-
财政年份:2012
-
负责人:A/Pr Cecile King
-
依托单位:
T helper cytokines in immunity and organ-specific autoimmunity
-
批准号:nhmrc : 1013208
-
项目类别:Career Development Fellowships
-
资助金额:$29.6万
-
财政年份:2011
-
负责人:A/Pr Cecile King
-
依托单位:
The role of interleukin (IL)-27 in the germinal centre reaction during normal and autoimmune responses
-
批准号:nhmrc : 1008558
-
项目类别:NHMRC Project Grants
-
资助金额:$31.75万
-
财政年份:2011
-
负责人:A/Pr Cecile King
-
依托单位:
The role of linked cytokines in T helper cell differentiation
-
批准号:nhmrc : 596836
-
项目类别:NHMRC Project Grants
-
资助金额:$26.04万
-
财政年份:2010
-
负责人:A/Pr Cecile King
-
依托单位:
The role of Interleukin-21 in the pathogenesis of autoimmune diabetes
-
批准号:nhmrc : 535934
-
项目类别:NHMRC Project Grants
-
资助金额:$32.61万
-
财政年份:2009
-
负责人:A/Pr Cecile King
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Interleukin1β炎症通路通过促进精胺代谢介
导抗癫痫药多药耐药的作用及机制研究
-
批准号:Q24H310010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:汤莹莹
-
依托单位:
凝血酶介导的 Interleukin-33 活化在二型免疫反应中功能机制研究
-
批准号:21ZR1470600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张亚光
-
依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究
-
批准号:81970025
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:高金明
-
依托单位:
Interleukin-1α和 Interleukin-1β调节大鼠Leydig干细胞增殖和分化的机制研究
-
批准号:LY19H040005
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:曹淑彦
-
依托单位:
Aquaporin介导的严重创伤后Interleukin-6致血脑屏障通透性增加的分子机制研究
-
批准号:81801909
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2018
-
负责人:杨思明
-
依托单位:
Interleukin 6/gp130信号通路影响白癜风移植疗效的机制
-
批准号:81271758
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:许爱娥
-
依托单位: